Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours – A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours – A systematic review and meta-analysis

Published:2023-03 Issue: Volume:182 Page:43-52
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Das Satya^ORCID,Phillips Sharon^ORCID,Lee Cody L.^ORCID,Agarwal Rajiv^ORCID,Bergsland Emily^ORCID,Strosberg Jonathan,Chan Jennifer A.,LaFerriere Heather^ORCID,Ramirez Robert A.^ORCID,Berlin Jordan^ORCID,Dasari Arvind

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference17 articles.

1. Angiogenesis in endocrine tumors;Turner;Endocr Rev,2003

2. New strategies for advanced neuroendocrine tumors in the era of targeted therapy;Dong;Clin Cancer Res,2012

3. Activity of sunitinib in patients with advanced neuroendocrine tumors;Kulke;J Clin Oncol,2008

4. Expression of vascular endothelial growth factor in digestive neuroendocrine tumors;Terris;Histopathology,1998

5. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis;Christofori;Mol Endocrinol,1995

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours;Endokrynologia Polska;2024-07-24

2. The metformin immunoregulatory actions in tumor suppression and normal tissues protection;Current Medicinal Chemistry;2023-07-03